Leonard W. Seymour
President at British Society for Gene & Stem Cell Therapy
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ian Gardiner | M | - |
University of Oxford
| - |
Bernard J. Taylor | M | 67 |
University of Oxford
| - |
Judith Patricia Armitage | M | - |
University of Oxford
| - |
George Radda | M | - |
University of Oxford
| - |
Peter Hunter | M | - |
University of Oxford
| - |
Anil Razdan | M | 75 |
University of Oxford
| - |
Jayne Almond | F | 67 |
University of Oxford
| - |
Ngaire Woods | F | 62 |
University of Oxford
| 14 years |
Peter Friend | M | - |
University of Oxford
| - |
André Finn | M | - |
University of Oxford
| - |
Len Blavatnik | M | 66 |
University of Oxford
| - |
Jeff Orenstein | M | - |
University of Oxford
| - |
Katherine Mary Barker | F | 66 |
University of Oxford
| - |
Marcus du Sautoy | M | - |
University of Oxford
| - |
Robert Fry | M | - |
University of Oxford
| - |
Malcolm McCulloch | M | - |
University of Oxford
| - |
Indrajit Wickramasinghe | M | - |
University of Oxford
| - |
Mike Chalfen | M | - |
University of Oxford
| - |
Cheryl Musch | F | - |
University of Oxford
| - |
Ronald Daniel | M | - |
University of Oxford
| - |
Robin Hanson | M | - |
University of Oxford
| - |
Stephen Pulman | M | - |
University of Oxford
| - |
Peter Grindrod | M | - |
University of Oxford
| - |
Lars Henrik Fugger | M | 64 |
University of Oxford
| 17 years |
Sheila Barrett | F | - |
University of Oxford
| - |
Hearth Henrietta | F | - |
University of Oxford
| 3 years |
Chas Bountra | M | 64 |
University of Oxford
| - |
Elish Angiolini | F | - |
University of Oxford
| - |
Li Jin | M | 54 |
University of Oxford
| - |
Robert MacLaren | M | 57 |
University of Oxford
| - |
J. Doyne Farmer | M | 72 |
University of Oxford
| - |
Zhan Feng Cui | M | 62 |
University of Oxford
| - |
David Kerr | M | - |
University of Oxford
| - |
Ashok Kumar Bhattacharya | M | 78 |
University of Oxford
| - |
Maria Damanaki | F | 72 |
University of Oxford
| - |
Robyn Norton | F | - |
University of Oxford
| - |
Stephen MacMahon | M | - |
University of Oxford
| - |
Leonard Charles William Seymour | M | 66 |
University of Oxford
| - |
Stephen Westaby | M | - |
University of Oxford
| - |
Matthew David Robson | M | 55 |
University of Oxford
| - |
Stefan Karl Neubauer | M | - |
University of Oxford
| - |
Jan Tadeusz Czernuszka | M | - |
University of Oxford
| - |
William Scott-Jackson | M | - |
University of Oxford
| - |
Geoffrey Hale | M | - |
University of Oxford
| - |
Alan J. Edwards | M | - |
University of Oxford
| - |
Soo Min Yeoh | F | 68 |
University of Oxford
| - |
Anthony Charles Hotson | M | 70 |
University of Oxford
| - |
Stephen Davies | M | 74 |
University of Oxford
| 28 years |
Bill Spitz | M | 72 |
University of Oxford
| - |
Patrick Pichette | M | 61 |
University of Oxford
| - |
Tiong Lu Koh | M | 68 |
University of Oxford
| - |
Herman Waldmann | M | - |
University of Oxford
| - |
Robert Charles Wigley | M | 63 |
University of Oxford
| - |
Robert J. Champion de Crespigny | M | - |
University of Oxford
| - |
Lai Kuen Louey | M | 64 |
University of Oxford
| 13 years |
John Bell | M | 71 |
University of Oxford
| 35 years |
Barden N. Gale | M | 73 |
University of Oxford
| - |
Alan J. Kingsman | M | 73 |
University of Oxford
| - |
Victor Blank | M | - |
University of Oxford
| - |
William Castell | M | 76 |
University of Oxford
| - |
Crispin Davis | M | 75 |
University of Oxford
| - |
Raj Bhikhu Parekh | M | 63 |
University of Oxford
| - |
William R. Miller | M | 95 |
University of Oxford
| - |
David M. Upton | M | 64 |
University of Oxford
| - |
Stephen George Franklin | M | 77 |
University of Oxford
| - |
André S. Hoffmann | M | 66 |
University of Oxford
| - |
Peter Ratcliffe | M | 69 |
University of Oxford
| - |
Geert Linnebank | M | 68 |
University of Oxford
| - |
E. Kristine Klavers | F | - |
University of Oxford
| - |
John Hagan Pryce Bayley | M | - |
University of Oxford
| 21 years |
Wendy Becker | F | 58 |
University of Oxford
| - |
Alan Moore | M | - |
University of Oxford
| - |
Patrick Thomas | M | 67 |
University of Oxford
| - |
John Martin O'Loan | M | - |
University of Oxford
| - |
David Kirn | M | 62 |
University of Oxford
| - |
Marc Feldmann | M | 79 |
University of Oxford
| 13 years |
Nigel Shadbolt | M | 68 |
University of Oxford
| - |
Lionel Tarassenko | M | 67 |
University of Oxford
| 27 years |
Michael Sydney Perry | M | - |
University of Oxford
| - |
Li Jin | M | 53 |
University of Oxford
| 12 years |
Benjamine Reid | M | - |
University of Oxford
| - |
Alex Hawker | M | - |
University of Oxford
| - |
Julie Baddeley | F | 73 |
University of Oxford
| - |
Simon Boddie | M | 64 |
University of Oxford
| 3 years |
Horace Deets | M | - |
University of Oxford
| - |
Adrian V. S. Hill | M | - |
University of Oxford
| - |
Jane Green | M | - |
University of Oxford
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kerry David Fisher | M | - |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | 8 years |
John Beadle | M | - |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | - |
Simon Freeman | M | - |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | - |
Gabor M. Rubanyi | M | 77 |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | - |
Mark Payton | M | 57 |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | - |
Phil L'Huillier | M | - |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | - |
Priya Mande | F | - |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 94 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Leonard W. Seymour
- Personal Network